Photo of Sara Shanti

Sara Helene Shanti is a partner in the Corporate Practice Group in the firm's Chicago office.

The Food and Drug Administration recently sought comments on the role of transparency for artificial intelligence and machine learning-enabled medical devices. The FDA invited comments in follow up to a recent workshop on the topic.

Continue Reading FDA Joins Other Regulators in Focus on AI and Machine Learning